These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 28099276

  • 1. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
    Gonzalez-L MD, Martinez C, Bori Y Fortuny I, Suso-Vergara S.
    Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
    [Abstract] [Full Text] [Related]

  • 2. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ, Glasson C, O'Flaherty SJ.
    Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
    [Abstract] [Full Text] [Related]

  • 3. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
    Savarese R, Diamond M, Elovic E, Millis SR.
    Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M, Gruber M, Bilish D, Edwards K, Davies-Payne D, van der Meer G.
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
    [Abstract] [Full Text] [Related]

  • 5. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreëls FJ, van Hulst K, Rotteveel JJ.
    Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
    [Abstract] [Full Text] [Related]

  • 6. What could predict effectiveness of Botulinum Toxin to treat drooling: a search for evidence of discriminatory factors on the level of body functions or structures.
    Erasmus CE, van Hulst K, Scheffer AR, van Limbeek J, van den Hoogen FJ, Rotteveel JJ, Jongerius PH.
    Eur J Paediatr Neurol; 2012 Mar; 16(2):126-31. PubMed ID: 21783393
    [Abstract] [Full Text] [Related]

  • 7. Secondary effects of botulinum toxin injections into salivary glands for the management of pediatric drooling.
    Reid SM, Walstab JE, Chong D, Westbury C, Reddihough DS.
    J Craniofac Surg; 2013 Jan; 24(1):28-33. PubMed ID: 23348253
    [Abstract] [Full Text] [Related]

  • 8. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.
    Reid SM, Johnstone BR, Westbury C, Rawicki B, Reddihough DS.
    Dev Med Child Neurol; 2008 Feb; 50(2):123-8. PubMed ID: 18201301
    [Abstract] [Full Text] [Related]

  • 9. Botulinum toxin injections for children with excessive drooling.
    Hassin-Baer S, Scheuer E, Buchman AS, Jacobson I, Ben-Zeev B.
    J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study.
    Hay N, Penn C.
    Int J Lang Commun Disord; 2011 Feb; 46(5):550-63. PubMed ID: 21899672
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Randomized controlled trial comparing botulinum vs surgery for drooling in neurodisabilities.
    Bekkers S, Delsing CP, Kok SE, van Hulst K, Erasmus CE, Scheffer ART, van den Hoogen FJA.
    Neurology; 2019 Mar 12; 92(11):e1195-e1204. PubMed ID: 30728311
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin-A injections vs radiotherapy for drooling in ALS.
    Weikamp JG, Schinagl DA, Verstappen CC, Schelhaas HJ, de Swart BJ, Kalf JG.
    Acta Neurol Scand; 2016 Sep 12; 134(3):224-31. PubMed ID: 26803950
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The impact of botulinum toxin type A in the treatment of drooling in children with cerebral palsy secondary to Congenital Zika Syndrome: an observational study.
    Sales HF, Cerqueira C, Vaz D, Medeiros-Rios D, Armani-Franceschi G, Lucena PH, Sternberg C, Nóbrega AC, Luz C, Fonseca D, Carvalho AL, Monteiro L, Siqueira IC, Bandeira ID, Lucena R.
    Neurol Res; 2021 Jan 12; 43(1):54-60. PubMed ID: 32915712
    [Abstract] [Full Text] [Related]

  • 17. Does motor performance matter in botulinum toxin efficacy for drooling?
    Erasmus CE, Scheffer AR, van Hulst K, van Limbeek J, van den Hoogen FJ, Rotteveel JJ, Jongerius PH.
    Pediatr Neurol; 2011 Aug 12; 45(2):95-9. PubMed ID: 21763949
    [Abstract] [Full Text] [Related]

  • 18. Onabotulinumtoxin A Treatment of Drooling in Children with Cerebral Palsy: A Prospective, Longitudinal Open-Label Study.
    Møller E, Pedersen SA, Vinicoff PG, Bardow A, Lykkeaa J, Svendsen P, Bakke M.
    Toxins (Basel); 2015 Jun 30; 7(7):2481-93. PubMed ID: 26134257
    [Abstract] [Full Text] [Related]

  • 19. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy.
    Suskind DL, Tilton A.
    Laryngoscope; 2002 Jan 30; 112(1):73-81. PubMed ID: 11802042
    [Abstract] [Full Text] [Related]

  • 20. Botulinum toxin A as a treatment for excessive drooling in children.
    Bothwell JE, Clarke K, Dooley JM, Gordon KE, Anderson R, Wood EP, Camfield CS, Camfield PR.
    Pediatr Neurol; 2002 Jul 30; 27(1):18-22. PubMed ID: 12160968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.